KRAS Mutations Testing in Colorectal Carcinoma Patients in Italy: From Guidelines to External Quality Assessment

BACKGROUND: Monoclonal antibodies directed against the epidermal growth factor receptor (EGFR) have been approved for the treatment of patients with metastatic colorectal carcinoma (mCRC) that do not carry KRAS mutations. Therefore, KRAS testing has become mandatory to chose the most appropriate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Normanno, Nicola, Pinto, Carmine, Castiglione, Francesca, Bardelli, Alberto, Gambacorta, Marcello, Botti, Gerardo, Nappi, Oscar, Siena, Salvatore, Ciardiello, Fortunato, Taddei, GianLuigi, Marchetti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244430/
https://www.ncbi.nlm.nih.gov/pubmed/22216189
http://dx.doi.org/10.1371/journal.pone.0029146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244430/
https://www.ncbi.nlm.nih.gov/pubmed/22216189
http://dx.doi.org/10.1371/journal.pone.0029146

Ejemplares similares